Early Insight
Focused on detecting biological signals before disease processes progress.
SCIENCE. INNOVATION. LONGEVITY.
Argeron is a life science innovation company developing advanced protein biomarker technologies, diagnostic platforms, medical devices, and longevity-focused formulations to better understand biological aging, support earlier scientific insight into age-related diseases, and help shape a healthier, longer human lifespan.
Focused on detecting biological signals before disease processes progress.
Health insight based on biological status, not only chronological age.
Protein biomarkers evaluated through measurable and verifiable methods.
Designed to help improve both lifespan potential and quality of life.
We develop high-reliability diagnostic solutions aligned with European standards.
We protect intellectual property and convert innovation into commercial value.
Discovery and validation of protein- and molecular-level biomarkers.
Scientific R&D focused on healthier life and improved quality of aging.
Creating value in global markets through internationally scalable solutions.
Developing solutions that contribute to human health and the future of care.
We investigate aging-related protein changes to better understand neurological risk at earlier stages.
Details
We aim to detect kidney injury early through trehalase activity and proprietary biomarker approaches.
Details
We research strong protein signatures for early detection and prognosis across multiple cancer areas.
Details
We analyze aging mechanisms at protein level to support healthier-life solutions.
Details
We identify early indicators of metabolic dysfunction to support long-term quality of life.
DetailsGlobally Patented Protein-Based Biological Age Analysis Platform
BioAgeCheck® is a globally patented biological age analysis platform based on protein-level biomarker analysis. The platform is designed to support the scientific evaluation of biological aging and biological processes associated with age-related diseases.

Early Detection of Kidney Injury
Measures urinary trehalase enzyme activity to help identify kidney injury earlier than conventional indicators.
NephroTesT® helps detect kidney injury earlier than traditional markers, but it is recommended to be used alongside clinical evaluation and other tests for diagnosis.

Magnetic Autoinjector Platform
An innovative autoinjector concept based on passive magnetic propulsion instead of conventional spring mechanisms.
Magoten® is an autoinjector platform based on passive magnetic propulsion instead of conventional spring mechanisms. This technology offers lower wear, longer service life, and innovative design. However, as with any injection device, proper training and appropriate techniques are essential before use.

Tube-Based Urine Collection and Transport System
A system designed to support urine sample collection, transport and pre-analytical stability.
Tit-UriCollect® is a system designed to support urine sample collection, transport and pre-analytical stability.

Deuterium-Depleted Alkaline Drinking Water
A premium drinking water concept with reduced deuterium level, alkaline profile and balanced mineral content.
Hafifsu® is a premium drinking water concept with reduced deuterium level, alkaline profile and balanced mineral content.

We understand aging more functionally through protein biomarker signatures.
Our work is supported by clinical research, academic partnerships and measurable science.
Our high-technology laboratory infrastructure and R&D capacity create strong differentiation.
We build internationally scalable solutions with the ambition to create global impact.
CE-certified products and regulatory experience support market readiness.
We develop technologies that contribute to human health and the future of biology-driven care.
2025
2025
2023
2022
2022
Argeron combines advanced biotechnology and biomarker science to help people live healthier, longer and higher-quality lives.